Verified Nov 2026
Other
·
Burlington, Massachusetts
·
Since 2003
BrainsWay is a medical technology company founded in 2003 that makes the Deep TMS System, a noninvasive neurostimulation device for mental health disorders. It is headquartered in Burlington, Massachusetts, with its parent operations in Jerusalem, Israel, and employs between 100 and 200 people. The company is publicly traded on NASDAQ and the Tel Aviv Stock Exchange under the ticker BWAY and serves psychiatrists, hospitals, and outpatient clinics. In January 2026 it announced FDA approval of a partner's neuromodulation system for major depressive disorder.
BrainsWay at a glance
Revenue
52.2M
Employees
100-200
Founded
2003
Headquarters
Burlington, Massachusetts
Ownership
Publicly traded (NASDAQ: BWAY)
Certifications
ISO 13485 · ISO 9001
Import activity
9
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Sourcing and import activity
From US customs bill-of-lading records
US sea imports
9
Named foreign suppliers
3
Top origins
Israel · Spain · Italy
Shared foreign counterparties do not establish that these companies buy from BrainsWay.
What this tells a buyer
BrainsWay reported first quarter 2026 financial results in May 2026, and in March 2026 it completed an additional $6 million milestone-based investment in Neurolief Ltd.
The company holds ISO 13485 and ISO 9001 certifications, and its Deep TMS System is FDA-cleared for major depressive disorder, obsessive-compulsive disorder, and smoking addiction.
BrainsWay reported annual revenue of about $52.2 million and in November 2025 disclosed a National Institutes of Health grant to a U.S. research team studying accelerated Deep TMS for alcohol use disorder.
Source: US customs bill-of-lading records and public filings · Last verified Nov 05, 2026
STABILITY SIGNALS
Established & strong
23 years in operation (founded 2003).
Publicly listed; no distress event on record.
Holds ISO 13485, ISO 9001 certification(s) per public sources.
Overview
BrainsWay is a medical technology company founded in 2003 that makes the Deep TMS System, a noninvasive neurostimulation device for mental health disorders. It is headquartered in Burlington, Massachusetts, with its parent operations in Jerusalem, Israel, and employs between 100 and 200 people. The company is publicly traded on NASDAQ and the Tel Aviv Stock Exchange under the ticker BWAY and serves psychiatrists, hospitals, and outpatient clinics. In January 2026 it announced FDA approval of a partner's neuromodulation system for major depressive disorder.
At a glance
Attribute | Detail |
|---|---|
Founded | 2003 |
Headquarters | Burlington, Massachusetts |
Employees | 100-200 |
Revenue | 52.2M |
Ownership | Publicly traded (NASDAQ: BWAY) |
Certifications | ISO 13485 · ISO 9001 |
What BrainsWay makes
The company holds ISO 13485 and ISO 9001 certifications, and its Deep TMS System is FDA-cleared for major depressive disorder, obsessive-compulsive disorder, and smoking addiction.
Products and capabilities described on the company's own site include LED (source: brainsway.com).
Certifications
BrainsWay is associated with the following certifications in public sources. Confirm the certified scope for the specific plant producing your part:
ISO 13485 — linkedin.com
ISO 9001 — linkedin.com
Trade and customs footprint
BrainsWay reported first quarter 2026 financial results in May 2026, and in March 2026 it completed an additional $6 million milestone-based investment in Neurolief Ltd. US customs bill-of-lading records list 9 inbound shipments across 3 foreign suppliers, with top origins including Israel · Spain · Italy.
Latest developments
2026-11-02 — BrainsWay Announces Strategic Collaboration with Mindful Health Solutions - BrainsWay (brainsway.com)
2026-05-13 — BrainsWay Reports First Quarter 2026 Financial Results and Operational Highlights (brainsway.com)
2026-03-26 — BrainsWay Completes Additional $6 Million Milestone-Based Investment in Neurolief Ltd. Following FDA Approval of Proliv™Rx System for MDD (brainsway.com)
2026-01-12 — BrainsWay Announces FDA Approval of Neurolief’s Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD) (brainsway.com)
2025-11-04 — BrainsWay Reports National Institutes of Health Grant to Leading U.S. Research Team Investigating Accelerated Deep TMS for Treatment of Alcohol Use Disorder - BrainsWay (brainsway.com)
2025-10-27 — BrainsWay Announces Additional Minority-Stake Investments in Leading U.S. Mental Health Providers (brainsway.com)
Company details
BrainsWay reported annual revenue of about $52.2 million and in November 2025 disclosed a National Institutes of Health grant to a U.S. research team studying accelerated Deep TMS for alcohol use disorder. BrainsWay was founded in 2003, has an estimated 100-200 employees, and is headquartered in Burlington, Massachusetts. On the LightSource stability read it is rated "Established & strong": 23 years in operation (founded 2003). Publicly listed; no distress event on record. Holds ISO 13485, ISO 9001 certification(s) per public sources.
Frequently asked questions
What does BrainsWay do?
BrainsWay is a medical technology company founded in 2003 that makes the Deep TMS System, a noninvasive neurostimulation device for mental health disorders. It is headquartered in Burlington, Massachusetts, with its parent operations in Jerusalem, Israel, and employs between 100 and 200 people. The company is publicly traded on NASDAQ and the Tel Aviv Stock Exchange under the ticker BWAY and serves psychiatrists, hospitals, and outpatient clinics. In January 2026 it announced FDA approval of a partner's neuromodulation system for major depressive disorder.
Where is BrainsWay headquartered?
BrainsWay is headquartered in Burlington, Massachusetts (1 Van de Graaff Dr, Burlington, Massachusetts, 01803-5171).
When was BrainsWay founded?
BrainsWay was founded in 2003.
How big is BrainsWay?
BrainsWay has an estimated 100-200 employees, with revenue in the 52.2M range.
Is BrainsWay publicly traded?
Publicly traded (NASDAQ: BWAY). Public financial figures are drawn from its filings.
What certifications does BrainsWay hold?
BrainsWay lists ISO 13485 · ISO 9001 on its website. Confirm the certified scope for the specific plant producing your part.
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile comes from a public-data sample of around 1,000 companies. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.